Chemoinformaics analysis of 2-phenylethyl valerate
| Molecular Weight | 206.285 | nRot | 6 |
| Heavy Atom Molecular Weight | 188.141 | nRig | 7 |
| Exact Molecular Weight | 206.131 | nRing | 1 |
| Solubility: LogS | -4.127 | nHRing | 0 |
| Solubility: LogP | 3.637 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 35.3163 |
| nHD | 0 | BPOL | 20.6617 |
| QED | 0.669 |
| Synth | 1.535 |
| Natural Product Likeliness | -0.06 |
| NR-PPAR-gamma | 0.052 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.009 |
| Pgp-sub | 0.002 |
| HIA | 0.003 |
| CACO-2 | -4.415 |
| MDCK | 0.0000302 |
| BBB | 0.558 |
| PPB | 0.931358 |
| VDSS | 0.942 |
| FU | 0.0594824 |
| CYP1A2-inh | 0.99 |
| CYP1A2-sub | 0.368 |
| CYP2c19-inh | 0.959 |
| CYP2c19-sub | 0.107 |
| CYP2c9-inh | 0.87 |
| CYP2c9-sub | 0.381 |
| CYP2d6-inh | 0.151 |
| CYP2d6-sub | 0.114 |
| CYP3a4-inh | 0.349 |
| CYP3a4-sub | 0.33 |
| CL | 12.499 |
| T12 | 0.81 |
| hERG | 0.128 |
| Ames | 0.032 |
| ROA | 0.037 |
| SkinSen | 0.93 |
| Carcinogencity | 0.319 |
| EI | 0.973 |
| Respiratory | 0.072 |
| NR-Aromatase | 0.023 |
| Antiviral | Yes |
| Prediction | 0.595532 |